Bicalutamide functions as a non-steroidal anti-androgen indicated for prostate management. Binding primarily to androgen receptors, the compound prevents hormonal signals that stimulate undesired tissue proliferation.
Bicalutamide belongs to the class of anti-androgen agents, chemicals that block the effects of male hormones at the cellular level. It is the active compound that gives several oncology medicines their therapeutic effect. In Singapore, this substance is recognized for its role in managing hormone-driven conditions, chiefly certain types of prostate cancer. The molecule works by attaching to androgen receptors, preventing natural hormones from binding and stimulating tumor growth.
Medicines that list bicalutamide as the key ingredient are available in tablet form, typically 50 mg or 150 mg strengths. Both generic versions and branded products are marketed under the same active name, allowing pharmacies to dispense the appropriate dosage based on a prescriber’s instruction. In local practice, these tablets are stored at room temperature, away from moisture, and are packaged to maintain stability throughout their shelf life.
These applications are directed toward adult patients whose disease characteristics indicate that hormone modulation could provide clinical benefit.
Bicalutamide competes with natural androgens for binding sites on cells that influence prostate tissue growth. By occupying these receptors without activating them, the drug blocks the signal that would otherwise tell cells to multiply. This blockade reduces the stimulus for tumor expansion, allowing other treatment components to act more effectively. The action is selective, meaning it mainly targets tissues where androgen receptors play a central role.
These effects are generally short-lived and resolve without medical intervention.
If any of these occur, immediate medical attention is warranted.
For a complete list of potential interactions, refer to the detailed information provided with each specific medication.
Store tablets in a dry place, away from direct sunlight, and keep them out of reach of children. Treatment duration varies: some regimens are short-term to assess response, while others continue for months or years as part of chronic disease management. Because strengths differ among products, the exact amount taken each day is determined by the prescribing clinician. For detailed usage, dosing, and administration, refer to the specific medication’s clinical information.
This article provides an educational overview of bicalutamide as an active substance and does not constitute medical advice. Individual medicines containing this agent may differ in formulation, strength, and instructions. The information presented carries no liability for clinical application. Patients should review the labeling of their specific product and seek guidance from a qualified healthcare professional when making health-related decisions.